SILO PHARMA, INC. Increase (Decrease) in Operating Assets
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Operating Assets of $84.01 thousand for the 3-month period ending 2013-12-31, per its 10-K filed 2014-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingAssets · last filed 2014-03-31
- SILO PHARMA, INC. increase (decrease) in operating assets for the quarter ending 2013-12-31 was $84.01K.
- SILO PHARMA, INC. increase (decrease) in operating assets for fiscal 2013 was $32.91K.
| Period end | Increase (Decrease) in Operating Assets 3 month | Increase (Decrease) in Operating Assets 12 month |
|---|---|---|
| 2013-12-31 | $84.01K 10-K · filed 2014-03-31 | $32.91K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |